Screener
Corvus Pharmaceuticals CRVS Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The source filing: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:05 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-057100
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $40,102 | $4,576 |
| Marketable securities | 196,612 | 52,174 |
| Accounts receivable - related party | 43 | 37 |
| Prepaid and other current assets | 3,189 | 1,427 |
| Total current assets | 239,946 | 58,214 |
| Property and equipment, net | 282 | 220 |
| Operating lease right-of-use asset | 751 | 839 |
| Investment in Angel Pharmaceuticals | 10,496 | 10,991 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Corvus Pharmaceuticals's prepaid & other current?
- Corvus Pharmaceuticals (CRVS) reported prepaid & other current of $3.19M in Q1 2026.
- How has Corvus Pharmaceuticals's prepaid & other current changed year-over-year?
- Corvus Pharmaceuticals's prepaid & other current increased by 165.8% year-over-year, from $1.2M to $3.19M.
- What is the long-term trend for Corvus Pharmaceuticals's prepaid & other current?
- Over 5 years (2020 to 2025), Corvus Pharmaceuticals's prepaid & other current has grown at a 5.8% compound annual growth rate (CAGR), from $1.08M to $1.43M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.
Ask your AI about Corvus Pharmaceuticals's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude